alzheimer

AI Reveals How Disrupted 3D DNA Architecture Triggers Alzheimer’s Disease

by

Researchers investigating neurodegenerative disorders are turning to artificial intelligence to decode how alterations in three-dimensional DNA architecture may serve as an early trigger for Alzheimer’s disease. By examining the complex folding patterns of the human genome and how these physical conformations influence gene activity, a specialized computational model known as Hicformer has provided fresh insights … Read more

Glucosamine Linked to Higher Alzheimer’s and Dementia Risk, Study Warns

by

Recent safety signals regarding the widely used supplement glucosamine have drawn urgent scrutiny from medical researchers examining potential long-term risks for patients with mild cognitive impairment. Clinical investigators are now closely evaluating whether chronic supplementation could accelerate neurodegenerative processes in vulnerable populations, prompting a fresh look at standard preventive guidelines for aging adults. The core … Read more

Il cervello cambia difese nella mezza età: cosa accade tra i 50 e i 75 anni – Mondosanità

by

Between the ages of 50 and 75, the human brain undergoes profound shifts in how it manages immune surveillance, cellular repair, and inflammatory defense mechanisms, according to recent neurological research and clinical observations. Rather than simply declining uniformly, the central nervous system modifies its protective strategies during mid-to-late life, balancing microglial activity with blood-brain barrier … Read more

New Tear Sensor Detects Dopamine: A Breakthrough for Early Parkinson’s Diagnosis

by

Researchers have developed a new diagnostic sensor capable of detecting dopamine levels in human tears, offering a potential non-invasive pathway for the early identification of Parkinson’s disease. By measuring these chemical concentrations, the device aims to provide a diagnostic marker years before traditional motor symptoms typically manifest, according to recent developments in biosensor technology reported … Read more

Early Alzheimer’s Detection: New Blood Tests and Gürtelrose Vaccination Breakthroughs

by

Recent clinical research suggests a potential link between the shingles vaccine and a reduced risk of Alzheimer’s disease, providing a fresh avenue for investigation in the field of neurodegenerative medicine. Simultaneously, advancements in blood-based diagnostic testing are beginning to offer more accessible, early-stage detection for Alzheimer’s, potentially transforming how clinicians identify patients at risk before … Read more

Cómo se está venciendo a la demencia – Infobae

by

Recent advancements in the clinical understanding and management of dementia have shifted the medical landscape from a focus on palliative care toward targeted, disease-modifying interventions. According to the World Health Organization, over 55 million people live with dementia worldwide, a number projected to nearly double every 20 years as populations age. While no singular cure … Read more

SGLT2 Inhibitors Reduce Alzheimer’s Risk by 43%: New Study Findings

by

Recent clinical research indicates that patients prescribed SGLT2 inhibitors—a class of medication primarily used to treat type 2 diabetes—may experience a significantly lower risk of developing Alzheimer’s disease. Data suggest that the anti-inflammatory and metabolic benefits of these drugs could play a protective role in neurological health, potentially reducing the incidence of dementia by 43% … Read more

Does Walking Speed Predict Longevity? The Science Behind Your Step Count and Health

by

Research into geriatric health has identified walking speed as a signal for how many years you will live. Clinical studies suggest that gait speed can serve as an indicator of longevity. While medical professionals have utilized walking pace to assess patient health, recent interest has focused on how changes in physical activity influence these outcomes. … Read more

Afternoon Confusion: The Classic Dementia Warning Sign Doctors Urge You to Never Ignore

by

Medical professionals frequently identify a phenomenon known as “sundowning”—or sundown syndrome—as a common behavioral manifestation associated with various forms of dementia, particularly Alzheimer’s disease. This condition is characterized by a distinct increase in confusion, agitation, and restlessness that typically emerges during the late afternoon or early evening hours. According to the National Institute on Aging … Read more

AI Retinal Scans Can Detect Alzheimer’s Disease 8.55 Years Early

by

Artificial intelligence is increasingly being deployed to identify the earliest physiological markers of Alzheimer’s disease, with recent research highlighting the potential to predict risk 8.55 years before clinical diagnosis. By analyzing patterns in retinal imaging and biomarker concentrations, medical researchers are attempting to shift the focus from late-stage symptom management to proactive, early-stage intervention. As … Read more